Hemolytic-uremic syndrome diagnostic study of choice

Jump to navigation Jump to search

Hemolytic-uremic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic-uremic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic-uremic syndrome diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic-uremic syndrome diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic-uremic syndrome diagnostic study of choice

CDC on Hemolytic-uremic syndrome diagnostic study of choice

Hemolytic-uremic syndrome diagnostic study of choice in the news

Blogs on Hemolytic-uremic syndrome diagnostic study of choice

Directions to Hospitals Treating Hemolytic-uremic syndrome

Risk calculators and risk factors for Hemolytic-uremic syndrome diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

There is no single diagnostic study of choice for the diagnosis of HUS.

Diagnostic Study of Choice

There is no single diagnostic study of choice for the diagnosis of hemolytic uremic syndrome (HUS), but HUS can be diagnosed based on clinical presentation along with lab findings of microangiopathic hemolytic anemia with low hemoglobin (Hb), low haptoglobin, high reticulocyte count and negative coombs test, thrombocytopenia with platelets less than 60,000 along with abnormal renal function as indicated with high blood urea nitrogen (BUN) and creatinine and electrolyte abnormalities. A diagnosis of atypical hemolytic uremic syndrome requires testing for antibodies to complement factors H and I or testing for mutations in complement proteins or receptors.[1]

References

  1. Wong EKS, Kavanagh D (2018). "Diseases of complement dysregulation-an overview". Semin Immunopathol. 40 (1): 49–64. doi:10.1007/s00281-017-0663-8. PMC 5794843. PMID 29327071.

Template:WH Template:WS